AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business ...
Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...
Shares of the company began plunging in November, but its overall strength should set the stock up for some serious potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback